Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

49.15
+3.216.99%
Pre-market: 49.680.5300+1.08%07:46 EST
Volume:27.71M
Turnover:1.35B
Market Cap:218.18B
PE:13.41
High:49.43
Open:47.07
Low:47.05
Close:45.94
52wk High:112.52
52wk Low:45.05
Shares:4.44B
Float Shares:3.19B
Volume Ratio:0.96
T/O Rate:0.87%
Dividend:1.71
Dividend Rate:3.49%
EPS(TTM):3.67
EPS(LYR):3.15
ROE:71.46%
ROA:20.43%
PB:8.73
PE(LYR):15.61

Loading ...

Metsera falls after FTC raises filing concerns over Novo bid

TIPRANKS
·
Nov 06

Mixed options sentiment in Novo Nordisk with shares down 0.78%

TIPRANKS
·
Nov 06

Novo Nordisk Stock (NVO) Falls after Medicare Price Deal and Q3 Earnings Miss

TIPRANKS
·
Nov 06

Market Movers | Digital Turbine Soars 31%; Unity Surges 11%; Rivian Jumps 10%; Pinterest Sinks 20%; Upstart Drops 11%

Tiger Newspress
·
Nov 05

Novo Nordisk Reports Strong Sales Growth Amid Restructuring Costs

TIPRANKS
·
Nov 05

Pre-Bell|U.S. Futures Rise; Unity Jumps 12%; Palantir Falls 2%; AMD Drops 3%; Super Micro Sinks 7%; Pinterest Tanks 19%

Tiger Newspress
·
Nov 05

Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. -- Barrons.com

Dow Jones
·
Nov 05

Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs

Benzinga
·
Nov 05

Jefferies Remains a Sell on Novo Nordisk (0QIU)

TIPRANKS
·
Nov 05

Novo Nordisk Accepts US Inflation Reduction Act Pricing for Semaglutide-Based Products

MT Newswires Live
·
Nov 05

Novo Nordisk (0QIU) Receives a Hold from UBS

TIPRANKS
·
Nov 05

Novo Nordisk reports Q3 EPS DKK 4.50 vs. DKK 6.12 last year

TIPRANKS
·
Nov 05

Novo Nordisk raises FY25 revenue view to up 8%-11% from up 4%-10%

TIPRANKS
·
Nov 05

Novo Nordisk Guidance Implies Cuts to Consensus Sales and Earnings -- Market Talk

Dow Jones
·
Nov 05

J.P. Morgan Sticks to Its Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Nov 05

Novo Nordisk's Narrowed Guidance Suggests Consensus Sales Downgrades -- Market Talk

Dow Jones
·
Nov 05

Novo Nordisk Q3 Adj. EPS $1.03 Beats $0.77 Estimate, Sales $11.745B Miss $11.880B Estimate

Benzinga
·
Nov 05

Dow Jones Top Company Headlines at 3 AM ET: Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster Drugs | Orsted ...

Dow Jones
·
Nov 05

Novo Nordisk Lowers Growth Forecast for Obesity and Diabetes Drugs, Shares Down Over 50% YTD

Deep News
·
Nov 05

Novo Nordisk Q3 Sales Beat Forecasts In New CEO's Maiden Quarter

Reuters
·
Nov 05